Clinical Trials Directory

Trials / Terminated

TerminatedNCT00994240

Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC

Cure Rates of Superficial Basal Cell Carcinoma Following 1 Versus 3 Cycles of Electrodessication & Curettage: A Randomized Prospective Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
85 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, randomized clinical trial conducted at the Unviersity of Wisconsin (UW) Dermatology Clinic located at 1 S. Park Street, Madison, WI 53715. There are no controls. Subjects meeting eligibility criteria are randomly divided into one of two treatment groups (ED\&C x 1 cycle or ED\&C x 3 cycles) using computer generated random numbers. One cycle of ED\&C is defined according to standard technique currently employed. It involves scraping away the tumor with a curette (ring- shaped instrument) and then burning the curetted site with a small electric needle (electrodessication). During Visit 1, the surgical site is marked, local numbing medication is injected, and 1 or 3 cycles of ED\&C is/are performed by board-certified dermatologists or a dermatology resident under the direct supervision of a board certified dermatologist. All follow-up visits (3, 6, 9, and 12 months after Visit 1) include skin evaluations by the physician who performed the ED\&C. The lesion site is examined, measured, and photographed for clinical evidence of recurrence, as defined by a new lesion within the previously treated site. If there is evidence of possible tumor recurrence at the treated surgical site during Visit 2, 3, 4 or 5, then the lesion will be biopsied using a shave procedure.

Conditions

Interventions

TypeNameDescription
PROCEDUREElectrodessication & CurettageElectrodessication \& Curettage 1 or 3 cycles

Timeline

Start date
2008-05-01
Primary completion
2013-08-01
Completion
2013-09-01
First posted
2009-10-14
Last updated
2015-02-27
Results posted
2015-02-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00994240. Inclusion in this directory is not an endorsement.

Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC (NCT00994240) · Clinical Trials Directory